Uveitis and clinical trials

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Uveitis refers to approximately 25 different diseases all characterized by the presence of intraocular inflammation. The uveitides are a relatively uncommon group of diseases, with an estimated incidence in the United States of 17–54/100,000/year and prevalence of 115–204/100,000 population. Nevertheless, because uveitis affects all ages, and in many cases is a lifelong disease, it has a disproportionate effect on years of potential vision lost and is the fifth or sixth leading cause of blindness in the United States. Because it is relatively uncommon, much of the information on uveitis comes from retrospective case series rather than from prospective epidemiologic studies or randomized clinical trials. Although these case series may provide the best data available, they are subject to several limitations, which must be understood in order to interpret the information properly.

Original languageEnglish (US)
Title of host publicationIntraocular Inflammation
PublisherSpringer Berlin Heidelberg
Pages123-135
Number of pages13
ISBN (Electronic)9783540753872
ISBN (Print)9783540753858
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Uveitis and clinical trials'. Together they form a unique fingerprint.

  • Cite this

    Jabs, D. A. (2016). Uveitis and clinical trials. In Intraocular Inflammation (pp. 123-135). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_7